Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
Xin Hong(Southern University of Science and Technology), Daniel A. Haber(Howard Hughes Medical Institute), David T. Miyamoto(Broad Institute), Keith T. Flaherty(Massachusetts General Hospital), John Milner(National Cancer Institute), Mark Kalinich(Harvard University), Ravi Kapur(Harvard University), Uyen Ho(Harvard University), Linda T. Nieman(Massachusetts General Hospital), Donald P. Lawrence(Massachusetts General Hospital), Joseph A. LiCausi(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Michael S. Lawrence(Broad Institute), Anita Giobbie‐Hurder(Institute for Tourism), Shiwei Pan(Harvard University), Lecia V. Sequist(Harvard University), Mehmet Toner(Shriners Hospitals for Children - Erie), Kurt J. Isselbacher(Harvard University), Tianqi Chen(Zhejiang A & F University), Ryan J. Sullivan(Massachusetts General Hospital), Sridhar Ramaswamy(Harvard University), Tanya T. Kwan(Howard Hughes Medical Institute)
Cited by 130
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k